| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jan Bakker | Q48283698 |
| P2093 | author name string | Gebhard Wagener | |
| Meghan Prin | |||
| P2860 | cites work | Epidemiology of severe sepsis | Q22305425 |
| Prevalence and incidence of severe sepsis in Dutch intensive care units | Q24800391 | ||
| Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence | Q24801390 | ||
| The role of ATP and adenosine in the control of hepatic blood flow in the rabbit liver in vivo | Q24802276 | ||
| A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts | Q28139627 | ||
| Determinants of splanchnic blood flow | Q28284692 | ||
| High arterial compliance in cirrhosis is related to low adrenaline and elevated circulating calcitonin gene related peptide but not to activated vasoconstrictor systems | Q28367063 | ||
| Liver fibrosis | Q29547449 | ||
| Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator | Q30457278 | ||
| Increased liver stiffness denotes hepatic dysfunction and mortality risk in critically ill non-cirrhotic patients at a medical ICU | Q30465982 | ||
| Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome | Q33357759 | ||
| Heterogeneous regional vascular responses to simulated transient hypovolemia in man. | Q33484275 | ||
| Assessment of intrahepatic blood flow by Doppler ultrasonography: relationship between the hepatic vein, portal vein, hepatic artery and portal pressure measured intraoperatively in patients with portal hypertension | Q33964515 | ||
| Liver cirrhosis | Q34010340 | ||
| Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality | Q74299021 | ||
| Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites | Q74367030 | ||
| An investigation of the relationship between portal venous pressure and inferior vena caval and portal venous oxygen saturations | Q74633635 | ||
| Blood volume distribution in patients with cirrhosis: aspects of the dual-head gamma-camera technique | Q77110569 | ||
| NO overproduction by eNOS precedes hyperdynamic splanchnic circulation in portal hypertensive rats | Q77307162 | ||
| Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis | Q77909622 | ||
| The control of the hepatic arterial circulation | Q79083871 | ||
| Endotoxemia contributes to the immune paralysis in patients with cirrhosis | Q79846664 | ||
| Risk factors for mortality after surgery in patients with cirrhosis | Q80098109 | ||
| Patients with acute on chronic liver failure display "sepsis-like" immune paralysis | Q81305036 | ||
| Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis | Q81783321 | ||
| Protein C activity and postoperative metabolic liver function after liver transplantation | Q84289108 | ||
| RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit | Q84595212 | ||
| The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α? | Q84736197 | ||
| Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit | Q84747667 | ||
| Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis | Q56925206 | ||
| Superior mesenteric artery impedance in chronic liver diseases: relationship with disease severity and portal circulation | Q57013803 | ||
| Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct–ligated rats | Q58308584 | ||
| Bacterial translocation of enteric organisms in patients with cirrhosis | Q58387749 | ||
| Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis | Q61409900 | ||
| Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis | Q61575972 | ||
| Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity | Q67277120 | ||
| Desensitization of myocardial beta-adrenergic receptors in cirrhotic rats | Q68477905 | ||
| Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow | Q68725475 | ||
| Maintenance of hepatic arterial blood flow during hemorrhage is mediated by adenosine | Q69404789 | ||
| Effects of splanchnic nerve stimulation on cardiac preload, afterload, and output in cats | Q71128994 | ||
| Hepatic capacitance responses to changes in flow and hepatic venous pressure in dogs | Q71462403 | ||
| Enhanced nitric oxide synthase activity in portal hypertensive rabbits | Q71704795 | ||
| Implication of L-type Ca2+ channels in noncholinergic adrenal catecholamine secretion by endothelin-1 in vivo | Q72006089 | ||
| Correlations between sinusoidal pressure and liver morphology in cirrhosis | Q72022169 | ||
| The interaction between hepatic arterial and portal venous blood flows; simultaneous measurement by transit time ultrasonic volume flowmetry | Q72315109 | ||
| Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells | Q72511375 | ||
| Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide | Q72853753 | ||
| Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis | Q73246449 | ||
| Inducible nitric oxide synthase gene knockout mice have increased resistance to gut injury and bacterial translocation after an intestinal ischemia-reperfusion injury | Q73249943 | ||
| Role of ET(A) and ET(B) receptors in endothelin-1-induced adrenal catecholamine secretion in vivo | Q73317027 | ||
| Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis | Q73584895 | ||
| Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis | Q73704445 | ||
| Plasma endothelin-1 levels in liver cirrhosis | Q73716634 | ||
| Prevalence of infections in intensive care units in Mexico: a multicenter study | Q73841365 | ||
| Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group | Q73934786 | ||
| Regulation of hepatic vascular volume: contributions from active and passive mechanisms during catecholamine and sodium nitroprusside infusion | Q73995064 | ||
| Hepatic vascular bed. | Q40061000 | ||
| Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis. | Q40442546 | ||
| Adenosine as putative regulator of hepatic arterial flow (the buffer response). | Q41279507 | ||
| Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response. | Q41603968 | ||
| Control of hepatic arterial blood flow: independence from liver metabolic activity | Q41646550 | ||
| Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis | Q41659336 | ||
| Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis | Q41773351 | ||
| Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites | Q41914372 | ||
| Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats | Q42200119 | ||
| Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver | Q42444902 | ||
| Protein C concentrations in severe sepsis: an early directional change in plasma levels predicts outcome | Q42905403 | ||
| Circulating vasopressin levels in septic shock. | Q43465970 | ||
| Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs | Q43568279 | ||
| Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival | Q43624302 | ||
| Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion | Q43649962 | ||
| Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis | Q43851678 | ||
| Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis | Q43858122 | ||
| Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. | Q44105999 | ||
| Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors | Q44178776 | ||
| Oxygen supply and uptake in the liver and the intestine | Q44277272 | ||
| Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study | Q44606985 | ||
| Outcomes of critically ill patients with cirrhosis admitted to intensive care: an important perspective from the non-transplant setting | Q44711643 | ||
| Circulation times in the splanchnic and hepatic beds in alcoholic liver disease | Q44955105 | ||
| The increasing burden of alcoholic liver disease on United Kingdom critical care units: secondary analysis of a high quality clinical database | Q45067345 | ||
| Decreased splanchnic perfusion measured by duplex ultrasound in humans undergoing small volume hemorrhage | Q45085453 | ||
| Epidemiology and outcomes of bloodstream infection in patients with cirrhosis | Q45227643 | ||
| Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis. | Q45715637 | ||
| Up-regulation of nNOS and associated increase in nitrergic vasodilation in superior mesenteric arteries in pre-hepatic portal hypertension | Q46553373 | ||
| ICU admission characteristics and mortality rates among elderly and very elderly patients | Q47148499 | ||
| Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey | Q47630913 | ||
| A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis | Q47839389 | ||
| Outcome predictors of cirrhosis patients admitted to the intensive care unit | Q47968970 | ||
| Cardiac hemodynamic profiles and pro-B-type natriuretic Peptide in cirrhotic patients undergoing liver transplantation | Q47986899 | ||
| Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites | Q48000999 | ||
| Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery | Q50538935 | ||
| Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. | Q50905896 | ||
| Anemia worsens hyperdynamic circulation of patients with cirrhosis and portal hypertension. | Q50936666 | ||
| Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. | Q51723077 | ||
| Splenic blood flow in cirrhosis and portal hypertension | Q52752365 | ||
| Trauma- and sepsis-induced hepatic ischemia and reperfusion injury: role of angiotensin II. | Q54044503 | ||
| Bacterial infection in the pathogenesis of variceal bleeding. | Q54104969 | ||
| Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition. | Q54106760 | ||
| Importance of nitric oxide in hepatic arterial blood flow and total hepatic blood volume regulation in pigs. | Q54152315 | ||
| The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats | Q54261204 | ||
| Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats. | Q54676425 | ||
| A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites. | Q54730500 | ||
| Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients | Q34027039 | ||
| Model for end-stage liver disease (MELD) and allocation of donor livers | Q34168541 | ||
| Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
| Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review | Q34223785 | ||
| Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. | Q34248963 | ||
| New approaches to sepsis: molecular diagnostics and biomarkers. | Q34303687 | ||
| Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease | Q34467402 | ||
| Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation | Q34496518 | ||
| Peribiliary myofibroblasts in biliary type liver fibrosis | Q34508576 | ||
| Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial | Q34546095 | ||
| The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database | Q34999455 | ||
| Vasopressin deficiency and vasodilatory state in end-stage liver disease | Q35118679 | ||
| Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity | Q35356530 | ||
| Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide | Q35595423 | ||
| Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. | Q35597966 | ||
| Angiogenesis in chronic inflammatory liver disease | Q35762577 | ||
| Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis | Q36209740 | ||
| Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience | Q36381386 | ||
| The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule | Q36382290 | ||
| Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats | Q36426811 | ||
| Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates | Q36510003 | ||
| Heart rhythm turbulence and NT-proBNP in decompensated liver cirrhosis--a pilot study. | Q36516487 | ||
| Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction | Q36940079 | ||
| Liver histology in ICU patients dying from sepsis: a clinico-pathological study | Q37220669 | ||
| Diagnosis and epidemiology of cirrhosis | Q37540941 | ||
| The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score. | Q37689311 | ||
| Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis | Q37767028 | ||
| Physiopathology of splanchnic vasodilation in portal hypertension | Q37821307 | ||
| Alcoholic cardiomyopathy: a review | Q37941148 | ||
| The role of angiotensin II in nonalcoholic steatohepatitis. | Q38009550 | ||
| Cirrhotic patients in the ICU: prognostic markers and outcome | Q38083176 | ||
| Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. | Q38451823 | ||
| Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study | Q39373943 | ||
| The influence of infection on hospital mortality for patients requiring > 48 h of intensive care. | Q39659525 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cirrhosis | Q147778 |
| sepsis | Q183134 | ||
| P304 | page(s) | 2582-2592 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Hepatosplanchnic circulation in cirrhosis and sepsis | |
| P478 | volume | 21 |
| Q38635623 | Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management |
| Q64078780 | Challenge to the Intestinal Mucosa During Sepsis |
| Q37117381 | Evaluation of liver function and electroacupuncture efficacy of animals with alcoholic liver injury by the novel imaging methods |
| Q64105998 | Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis |
| Q31166756 | Phase-contrast MR flow imaging: A tool to determine hepatic hemodynamics in rats with a healthy, fibrotic, or cirrhotic liver |
| Q28076873 | The digestive tract as the origin of systemic inflammation |
Search more.